Stockreport

Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 [Yahoo! Finance]

INTEGRATED BIOPHARMA INC  (INBP) 
US:NASDAQ Investor Relations: ibiopharma.com
PDF Revenue for the quarter ended June 30, 2024 was $12.7 million compared to $13.0 million for the quarter ended June 30, 2023, a decrease of $0.3 million or 2.3%. The Com [Read more]